Today

Agents

Chat

Arena

Discover

More

App

Century Therapeutics appoints iECURE CEO Joseph Truitt to board - IPSC News | Rallies

Century Therapeutics appoints iECURE CEO Joseph Truitt to board

IPSC•2026-09-09

Background

He is chairman at Larimar Therapeutics, serves on Code Biotherapeutics’ board, and led BioSpecifics until its 2020 Endo acquisition.

Truitt previously held senior roles at Achillion Pharmaceuticals, including CEO, before its 2020 acquisition by Alexion Pharmaceuticals.

Board appointment

Century Therapeutics appointed Joseph Truitt to its board of directors.

Truitt is CEO and a board member at iECURE.

Related News

UDR keeps FY 2026 same-store revenue growth outlook at 0.75%-2%

UDR•2026-09-09

Easterly Government Properties joins Evercore Real Estate Conference investor meetings

DEA•2026-09-09

Kewaunee Scientific Q1 sales fall due to challenging market conditions

•

2026-09-09

AeroVironment Q1 results beat estimates on higher product and service sales growth

AVAV•2026-09-09

Phibro Animal Health to Present at Morgan Stanley Global Healthcare Conference

PAHC•2026-09-09